Found 23 matching trials
Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry N/A The purpose of this study is to see if it is possible to establish a relati...
Show More Location
Rush University Medical Center
Learn More & Join Trial
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation N/A The purpose of this study is to study the way radioembolization works by co...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer PHASE2 This phase II trial tests how well cemiplimab and transarterial radioemboli...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Affordable Made-in-India Microspheres for Liver Cancer Therapy PHASE1 Primary liver tumors, with hepatocellular carcinoma (HCC) accounting for 80...
Show More Location
Postgraduate Institute of Medical Education and Research
Learn More & Join Trial
Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC) PHASE2 This is an open-label, multi-center, randomized phase II study comparing th...
Show More Location
Georgetown University
Learn More & Join Trial
Radioembolization Versus External Radiation Therapy PHASE2 The proposed study is a single site, prospective, randomized phase 2 study ...
Show More Location
Henry Ford Health System
Learn More & Join Trial
Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma NA The purpose of this study is to determine the safety and maximum tolerated ...
Show More Location
Medical University of South Carolina
Learn More & Join Trial
A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE PHASE2 The purpose of this study is to measure the efficacy and safety of durvalum...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma PHASE2 This is a prospective, open-label, single-arm, investigator-initiated study...
Show More Location
The Second Affiliated Hospital, Guangzhou Medical University
Learn More & Join Trial
Defining the Ablative Dose for Y-90 TARE PHASE2 This study is being done to help doctors improve how they treat liver tumor...
Show More Location
Northwestern University
Learn More & Join Trial